IMMXImmix Biopharma Inc. Common Stock
13.66USD+3.56%Mkt Cap: 972.45M $P/E: —3d ago
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Aus…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap972.45M $
Enterprise Value710.35M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-29.44M $
Revenue/Share—
Last Price13.66 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees21
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-14.56
PEG—
EV/EBITDA-17.12
EV/Revenue—
P/S—
P/B4.11
EPS (TTM)-0.88
EPS (Forward)-0.90
52W Range
1.94099% of range13.76
52W High13.76 USD
52W Low1.940 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-31.39%
ROA-28.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.93M $
CapEx (TTM)732.92K $
FCF Margin—
FCF Yield-2.61%
Net Debt-231.11M $
Net Debt/EBITDA5.57
Balance Sheet
Debt/Equity0.01
Current Ratio25.13
Quick Ratio24.95
Book Value/Sh3.200 USD
Cash/Share3.244 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.27 USD
Upside (mean)+48.4%
Target Range13.20 USD – 27.00 USD
$13.20+48.4% to mean$27.00
# Analysts8
Ownership
Shares Out.71.19M
Float56.17M
Insiders17.13%
Institutions78.88%
Short Interest
Short Ratio5.1d
Short % Float16.12%
Short % Out.13.33%
Shares Short9.49M
Short (prev mo.)7.88M
Technical
SMA 509.925 (+37.6%)
SMA 2007.932 (+72.2%)
Beta0.11
S&P 52W Chg18.16%
Avg Vol (30d)1.60M
Avg Vol (10d)1.53M
Technical Indicators
RSI (14)74.1
MACD0.8022
MACD Signal0.3763
MACD Hist.+0.4259
BB Upper13.24 USD
BB Middle9.982 USD
BB Lower6.719 USD
BB Width65.37%
ATR (14)0.8549 USD
Vol Ratio (20d)0.97x